about
Role of pregnane X receptor in chemotherapeutic treatmentCytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effectA novel mathematical model describing adaptive cellular drug metabolism and toxicity in the chemoimmune systemCytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation11-Hydroxythromboxane B2 dehydrogenase is identical to cytosolic aldehyde dehydrogenaseNeutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseasesCytochrome P450-based cancer gene therapy: recent advances and future prospects.A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC)Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complexCyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study.Oxazaphosphorines: new therapeutic strategies for an old class of drugs.Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.Aldehyde dehydrogenases and their role in carcinogenesis.Metabolism of ifosfamide during a 3 day infusion.Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM.Antimycotic drug discovery in the age of genomics.Metabolism and transport of oxazaphosphorines and the clinical implications.In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas.Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in miceMetabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancerCyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.A comprehensive survey of the mutagenic impact of common cancer cytotoxicsEnhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.The influence of amifostine administration prior to cyclophosphamide on in vitro maturation of mouse oocytes.Urological implications of cyclophosphamide and ifosfamide.Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.Cytochrome P450-activated prodrugs.Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.Methanolic Extract of Curcuma caesia Roxb. Prevents the Toxicity Caused by Cyclophosphamide to Bone Marrow Cells, Liver and Kidney of Mice.Simple relations between administered and internal doses in compartmental flow models.Xenobiotic oxidation catalyzed by aldehyde dehydrogenases.The effect of N-acetylcysteine on the antitumor activity of ifosfamide.Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein.In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients.
P2860
Q26827398-C0371E21-2D33-44ED-8D58-E8703F04D555Q28344743-9A473B3D-D74B-447A-A24E-B8DF2D93B074Q28543628-DEB8A2CD-6AFD-4358-B7A4-18E66EBEFD19Q28550763-8BA1D2A0-408F-46CE-BF51-0D09C4BEC434Q28623241-69756251-E724-4884-BD0A-3FDF89EFDBADQ33236887-908C8C6F-324A-4759-A729-A536AD619F31Q33639790-51305A97-04F5-49FC-B34C-7F3AF326A4E3Q33653106-2BF287A7-1B77-4EAF-8FA7-5068C834FA1BQ33783874-1C056086-F6E4-4CCA-BFA5-04135B076B4DQ34048033-B8E9FC53-8EC9-4447-8A11-0E061A45556CQ34113899-0305A9A1-5BC2-4E34-9069-2E8AEA70FEB8Q35058030-9A5A1330-8277-434D-A8E0-6E62CCEA1B11Q35745249-F50FE083-F956-481C-9E9D-455CAE098372Q35815650-3FA172B1-8308-45CE-9122-64F016CA1F59Q35978501-21F1C93C-4F78-4BB2-9D93-0841189D3F90Q36055447-DBF5D489-E4A6-4C0D-82AE-2082EA44A851Q36334753-AA915A69-4B4D-4153-AD4F-3B8D4929B443Q36360811-AAA2642C-82EE-4CCA-86DA-BF6340FEC4FFQ36419989-5B9F02E5-6F47-43FB-9CE7-726FE41194FFQ36453630-DEB0C468-7E5C-48BF-87C6-98ED28DF0546Q36466156-BA614FFB-9E49-44C5-ACAC-BC49EE4C4AC6Q36616877-DF31174A-B8E9-493A-A987-5CAC9D70B098Q36652629-9A20A998-EFA2-45E5-98FE-6B1E9492F003Q36886849-6B167DD0-0FF3-49C5-BECC-D411E645FA76Q37037051-D082F9A9-D10C-4AA4-BA38-563F8B0B1942Q37049967-41F08819-9E0D-4684-8A1C-C1C549129A66Q37264407-303C13ED-BA2A-470C-947F-CD59E990AC9CQ37386327-9C88F04B-7E83-43BD-8B8E-695719DCB617Q37505854-6F7DFBAA-537D-40C8-AED1-78E77CDA30E8Q37707385-CFB31C35-516F-492C-8C0F-7CF38FE2A453Q38077550-132E120C-F01F-4D95-9903-D4115C3204B3Q38166071-8FCCB025-1841-4891-9BE1-D62B2C74D05AQ38291073-6B49C16D-89C4-4F34-9F02-EDE07B6AF18BQ38441908-70378408-42B9-4B84-8C50-3A9034935653Q38574641-0D7492C7-AEF7-4947-AD66-4471CC181804Q38709529-0602B359-A121-4B17-9289-4BB195D75868Q39537262-8288F037-A574-4F93-B575-3788FAA157E4Q39691802-27131041-DEB9-46C5-81FA-9540E22F7D8BQ40450759-E9A306A5-3567-440F-8718-C4C3058BB114Q40463535-3F7A1DB9-71E6-4369-9ADC-F45330F1287D
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Metabolism of oxazaphosphorines.
@en
Metabolism of oxazaphosphorines.
@nl
type
label
Metabolism of oxazaphosphorines.
@en
Metabolism of oxazaphosphorines.
@nl
prefLabel
Metabolism of oxazaphosphorines.
@en
Metabolism of oxazaphosphorines.
@nl
P1476
Metabolism of oxazaphosphorines.
@en
P2093
P304
P356
10.1016/0163-7258(88)90004-6
P577
1988-01-01T00:00:00Z